Who manufactures Promacta?
Eltrombopag, sold under the brand name Promacta among others, is a medication used to treat thrombocytopenia (abnormally low platelet counts) and severe aplastic anemia. Promacta (eltrombopag) is known as Revolade® outside the U.S. and is marketed worldwide by Novartis. It is a thrombopoietin receptor agonist.
Is there a generic for Promacta?
Eltrombopag is the generic name for the trade name drug Promacta. In some cases, health care professionals may use the trade name, Promacta, when referring to the generic drug name, eltrombopag.
What is the cost of Promacta?
Platelets are the cells primarily responsible for blood clotting, so low blood platelets leave patients vulnerable to bleeding and bruising. The active ingredient in Promacta, eltrombopag, activates bone marrow to produce blood platelets. Promacta costs $11,568.3 at full price.
Is Promacta a specialty medication?
The Limited Distribution Medication Promacta can only be dispensed by a designated network of specialty pharmacies.
Who makes eltrombopag?
Promacta Earns Breakthrough Therapy Designation by FDA for Severe Aplastic Anemia. Recently, the FDA granted a breakthrough therapy designation to eltrombopag (Promacta, Novartis) for combination use with standard immunosuppressive therapy as a first-line treatment for patients with severe aplastic anemia (SAA).
Is PROMACTA a chemo drug?
Eltrombopag (Promacta) is an FDA approved drug for the treatment of chronic idiopathic thrombocytopenic purpura (ITP)- a condition of having an abnormally low platelet count….Eltrombopag for the Prevention of Chemotherapy Induced Thrombocytopenia.
|Last Update Posted:||April 2, 2014|
|Last Verified:||April 2013|
Is Promacta a chemo drug?
How long can you take Promacta?
The recommended dosage of Promacta for the treatment of severe aplastic anemia (SAA) is 150 mg once a day for 6 months. Promacta will be used with immunosuppressive therapy, which is a kind of treatment that decreases the activity of your immune system.
How long can you take promacta?
Is promacta a chemo drug?
What class of drug is PROMACTA?
Eltrombopag is in a class of medications called thrombopoietin receptor agonists. It works by causing the cells in the bone marrow to produce more platelets.
What kind of drug is PROMACTA?
Promacta (eltrombopag) is a thrombopoietin (TPO) receptor agonist, a man-made form of a protein, used to prevent bleeding episodes in people with chronic immune thrombocytopenic purpura (ITP), a bleeding condition caused by a lack of platelets in the blood.
What is Promacta used to treat?
PROMACTA is indicated for the treatment of patients with severe aplastic anemia who have had an insufficient response to immunosuppressive therapy.
Does Promacta cause hepatotoxicity?
PROMACTA may increase the risk of severe and potentially life-threatening hepatotoxicity. Measure serum alanine aminotransferase (ALT), aspartate aminotransferase (AST), and bilirubin prior to initiation of PROMACTA, every 2 weeks during the dose-adjustment phase, and monthly following establishment of a stable dose
When should Promacta be used to treat hepatitis C?
PROMACTA should be used only in patients with chronic hepatitis C whose degree of thrombocytopenia prevents the initiation of interferon-based therapy or limits the ability to maintain interferon-based therapy.
When to discontinue Promacta after 16 weeks?
If no hematologic response has occurred after 16 weeks with PROMACTA, discontinue therapy PROMACTA must be taken at least 2 hours before or 4 hours after any medications or products containing polyvalent cations such as antacids, calcium-rich foods, and mineral supplements